Vascular engineering using human embryonic stem cells

Engineering vascularized tissue constructs remains a major problem in regenerative medicine. The formation of such a microvasculature—like the vasculogenesis in early embryogenesis that it closely resembles—is guided by biochemical and biophysical cues, such as growth factors, extracellular matrix proteins, hypoxia, and hydrodynamic shear. As they undergo spontaneous and directed vascular differentiation, human embryonic stem cells can be used as a model system to explore central issues in engineering vascularized tissue constructs and, potentially, to elucidate vasculogenic and angiogenic mechanisms involved in such vascular diseases as limb and cardiac ischemia. Because the conventional spontaneous differentiation approach can only isolate small quantities of vascular cells, recent efforts have sought to develop controlled approaches, including the development of three‐dimensional scaffolds to reengineer the microenvironments of early embryogenesis. This review focuses on emerging approaches to deriving and directing vasculatures from human embryonic stem cells and efforts to engineer 3D vasculatures from such derivatives. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009

[1]  J. Wieslander,et al.  Dextran's antithrombotic properties in small arteries are not altered by low‐molecular‐weight heparin or the fibrinolytic inhibitor tranexamic acid: An experimental study , 1993, Microsurgery.

[2]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[3]  I Hüttner,et al.  Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[4]  H. Chung,et al.  Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  Joyce Bischoff,et al.  Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[6]  Mitchell D. Probasco,et al.  Feeder-independent culture of human embryonic stem cells , 2006, Nature Methods.

[7]  Robert Langer,et al.  Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[8]  D. S. Letbetter,et al.  Surface-immobilized dextran limits cell adhesion and spreading. , 2000, Biomaterials.

[9]  Chunhui Xu,et al.  Feeder-free growth of undifferentiated human embryonic stem cells , 2001, Nature Biotechnology.

[10]  G. Dressler Chapter Fifty-Two – Stem Cells in Kidney Development and Regeneration , 2007 .

[11]  E. Domany,et al.  Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[12]  G. Yancopoulos,et al.  Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.

[13]  M. Zink,et al.  Endothelial cells from diverse tissues exhibit differences in growth and morphology. , 1998, Microvascular research.

[14]  A. Lumsden,et al.  Roles of Hemodynamic Forces in Vascular Cell Differentiation , 2005, Annals of Biomedical Engineering.

[15]  H. Baldwin,et al.  Relationship of the extracellular matrix to coronary neovascularization during development. , 1996, Journal of molecular and cellular cardiology.

[16]  R. Savani,et al.  Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras‐transformed cells , 1994, Journal of cellular biochemistry.

[17]  M. Schuldiner,et al.  Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers , 1999 .

[18]  W. Aird Endothelial cell heterogeneity , 2003, Critical care medicine.

[19]  S. Kumar,et al.  The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.

[20]  Sean P. Palecek,et al.  The response of human embryonic stem cell-derived endothelial cells to shear stress. , 2008, Biotechnology and bioengineering.

[21]  S. Levenberg Engineering blood vessels from stem cells: recent advances and applications. , 2005, Current opinion in biotechnology.

[22]  W. Risau Differentiation of endothelium , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  C. Chu,et al.  In Vitro Release Behavior of Dextran-Methacrylate Hydrogels Using Doxorubicin and other Model Compounds , 2000, Journal of biomaterials applications.

[24]  C. van Nostrum,et al.  Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins. , 2004, International journal of pharmaceutics.

[25]  Reine Bareille,et al.  Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: A pre-requisite for vascular tissue engineering , 2007, Journal of materials science. Materials in medicine.

[26]  S. Gerecht,et al.  A porous photocurable elastomer for cell encapsulation and culture. , 2007, Biomaterials.

[27]  S. Gerecht,et al.  Vascular Progenitor Cells Isolated From Human Embryonic Stem Cells Give Rise to Endothelial and Smooth Muscle–Like Cells and Form Vascular Networks In Vivo , 2007, Circulation research.

[28]  T. Shinoka Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. , 2002, Artificial organs.

[29]  Elias T. Zambidis,et al.  Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. , 2005, Blood.

[30]  Smadar Cohen,et al.  Human Embryonic Stem Cells as an In Vitro Model for Human Vascular Development and the Induction of Vascular Differentiation , 2003, Laboratory Investigation.

[31]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[32]  Yu Chen,et al.  Generation of functional hemangioblasts from human embryonic stem cells , 2007, Nature Methods.

[33]  S. Nishikawa,et al.  Pathway for Differentiation of Human Embryonic Stem Cells to Vascular Cell Components and Their Potential for Vascular Regeneration , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[34]  C. Garlanda,et al.  Heterogeneity of endothelial cells. Specific markers. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[35]  A. Sambanis Chapter Forty-Two – Bioartificial Pancreas , 2007 .

[36]  B. Toole,et al.  Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.

[37]  M. Capogrossi,et al.  Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. , 2006, Circulation research.

[38]  Shulamit Levenberg,et al.  Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Sittinger,et al.  Retention of hyaluronic acid in alginate beads: aspects for in vitro cartilage engineering. , 1999, Journal of biomedical materials research.

[40]  J. Itskovitz‐Eldor,et al.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. A. Hubbell Chapter Twenty-One – Matrix Effects , 2007 .

[42]  L. Niklason,et al.  Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs) , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[44]  S. Kumar,et al.  Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[45]  James A. Thomson,et al.  Hematopoietic colony-forming cells derived from human embryonic stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Slevin,et al.  Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses* , 2002, The Journal of Biological Chemistry.

[47]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[48]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[49]  G. Keller,et al.  Hypoxia affects mesoderm and enhances hemangioblast specification during early development , 2004, Development.

[50]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[51]  J. Dordick,et al.  Biocatalytic synthesis of highly ordered degradable dextran-based hydrogels. , 2005, Biomaterials.

[52]  K. Leong,et al.  The design of scaffolds for use in tissue engineering. Part I. Traditional factors. , 2001, Tissue engineering.

[53]  Lisheng Wang,et al.  Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. , 2004, Immunity.

[54]  J. Itskovitz‐Eldor,et al.  Controlled, Scalable Embryonic Stem Cell Differentiation Culture , 2004, Stem cells.

[55]  Joao Maia,et al.  Synthesis and characterization of new injectable and degradable dextran-based hydrogels , 2005 .

[56]  Jae Min Lim,et al.  Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell–Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia , 2007, Circulation.

[57]  J. V. Alstine,et al.  Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. , 1995, Journal of biomedical materials research.

[58]  J. Ando,et al.  Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading , 2005, Journal of Artificial Organs.

[59]  R. Langer,et al.  Endothelial potential of human embryonic stem cells. , 2007, Blood.

[60]  R. Jain,et al.  Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo , 2007, Nature Biotechnology.

[61]  G. Smith,et al.  Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. , 2005, Tissue engineering.

[62]  Qizhi Yao,et al.  Shear Stress Induces Endothelial Differentiation From a Murine Embryonic Mesenchymal Progenitor Cell Line , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[63]  M. Simon,et al.  HIFs, hypoxia, and vascular development. , 2004, Current topics in developmental biology.

[64]  G. Thorgeirsson,et al.  The vascular endothelium-pathobiologic significance. , 1978, The American journal of pathology.

[65]  D. Kohane,et al.  Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.

[66]  William C. Aird,et al.  Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.

[67]  Robert Langer,et al.  Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. , 2005, Biomacromolecules.

[68]  M. Gassmann,et al.  Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Bryan Heit,et al.  Measuring Chemotaxis and Chemokinesis: The Under-Agarose Cell Migration Assay , 2003, Science's STKE.

[70]  Alan Wells,et al.  Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. , 2007, Advances in cancer research.

[71]  W. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds , 2007, Circulation research.

[72]  J. Thomson,et al.  Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. , 2005, Blood.

[73]  P. Carmeliet,et al.  Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. , 1999, Current topics in microbiology and immunology.

[74]  Dwayne G Stupack,et al.  ECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands , 2002, Science's STKE.

[75]  Lewis H Romer,et al.  Focal Adhesions Paradigm for a Signaling Nexus , 2006 .

[76]  J. Dordick,et al.  Biocompatibility of chemoenzymatically derived dextran-acrylate hydrogels. , 2004, Journal of biomedical materials research. Part A.

[77]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[78]  P. Carmeliet Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[79]  G. Semenza,et al.  Regulation of angiogenesis by hypoxia-inducible factor 1. , 2006, Critical reviews in oncology/hematology.

[80]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[81]  Gordana Vunjak-Novakovic,et al.  Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. , 2007, Biomaterials.

[82]  J. Itskovitz‐Eldor,et al.  Three‐dimensional porous alginate scaffolds provide a conducive environment for generation of well‐vascularized embryoid bodies from human embryonic stem cells , 2004, Biotechnology and bioengineering.

[83]  J. Folkman,et al.  Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border , 1998, Cell.